Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › SSRI

SSRI

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of SSRI

8 trials tracked of SSRI: 7 in phase 3 or 4 and 4 with published results. The most-cited published study has 12 citations.

8Trials tracked
7Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 1 Phase 3 6 Other / NA 1
  1. Phase 3 A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder Completed · 12 cited
  2. Phase 3 A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment Completed · 12 cited
  3. Phase 3 A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Completed · 12 cited
  4. Phase 3 A Study in Prevention of Re-emergence of Depression Symptoms Completed · 10 cited
  5. Phase 4 Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients Completed
  6. Phase 3 A Safety Study in Participants With Major Depressive Disorder Completed
Show 2 more trials
  1. Phase 3 A Study of LY2216684 in Participants With Major Depression Disorder Completed
  2. N/A A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Genotype-Guided SSRI Prescribing Shows No Short-Term Benefit but Higher Remission at 6 Months
Genetics & Precision Medicine RCT
Genotype-Guided SSRI Prescribing Shows No Short-Term Benefit but Higher Remission at 6 Months Genetic Testing Helps Some Depression Patients Feel Better Long Term
This randomized clinical trial compared genotype-guided SSRI prescribing to usual care in 1460 patients with depression. At 3 months, there …
• Genetic-guided SSRI prescriptions boost six-month remission rates for certain patients • Helps people with specific gene variations affect…
May 6, 2026